āļāļēāļĢāļ§āļīāļāļąāļĒāđāļāļīāļāļĨāļķāļāđāļĨāļ°āļāļđāđāļĄāļ·āļāļāļđāđāđāļāļĩāđāļĒāļ§āļāļēāļāđāļāļĩāđāļĒāļ§āļāļąāļāļāļēāļĢāļĢāļąāļāļĐāļēāļŠāļļāļāļ āļēāļāļŠāļēāļĒāļāļēāļāļāļāļāļļāļ
AI for Glaucoma Detection and Prognosis: Performance, Bias, and Clinical Integration in 2025 Glaucoma is a leading cause of irreversible blindness, affecting over 90 million people worldwide (pmc.ncbi.nlm.nih.gov). Worryingly, more than 70% of glaucoma cases remain undiagnosed (pmc.ncbi.nlm.nih.gov). Early detection is crucial because vision loss from glaucoma cannot be undone. In recent years, a...
Autofagija un glaukoma: pÄrvÄrtÄjam neiroprotekciju Glaukoma ir optiskÄ neiropÄtija, ko raksturo progresÄjoÅĄa tÄŦklenes ganglija ÅĄÅŦnu (RGC) un to aksonu zudums, kas noved pie neatgriezeniskas redzes pasliktinÄÅĄanÄs (pmc.ncbi.nlm.nih.gov). TradicionÄli glaukoma tiek ÄrstÄta, pazeminot acu iekÅĄÄjo spiedienu (IOP), taÄu to arvien vairÄk atzÄŦst par neirodeÄĢeneratÄŦvu slimÄŦbu. LÄŦdz brÄŦdim, kad parÄdÄs...
Ginkgo Biloba for Visual Field Preservation: A Critical Appraisal Glaucoma is a leading cause of irreversible blindness worldwide, characterized by retinal ganglion cell loss and progressive visual field impairment (pmc.ncbi.nlm.nih.gov). While elevated intraocular pressure (IOP) is the main modifiable risk factor, many patients â especially those with normal-tension glaucoma (NTG) â progress desp...
āđāļĢāļīāđāļĄāļāļēāļĢāļāļāļŠāļāļāļĨāļēāļāļŠāļēāļĒāļāļēāļāļĢāļĩāļāļāļāļāļļāļāđāļāđāļ§āļĨāļēāļāđāļāļĒāļāļ§āđāļē 5 āļāļēāļāļĩ
āđāļĢāļīāđāļĄāļāļāļŠāļāļāļāļąāļāļāļĩThe whole area you can see when your eyes are fixed on a point, including side (peripheral) vision. Visual field tests find blind spots or areas of vision loss, which is important for detecting and tracking diseases like glaucoma.
ðĨāļāļāļāļ§āļēāļĄāļĒāļāļ
